Current concepts in the management of intracranial atherosclerotic disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17053605.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Medically refractory, symptomatic intracranial atherosclerotic disease has a poor prognosis. Based on the results of the Warfarin-Aspirin Symptomatic Intracranial Disease study, the risk of ipsilateral stroke at 1.8 years is between 13 and 14% in patients with symptomatic intracranial atherosclerosis. Synergistic advances in intracranial angioplasty and stenting, modern neuroimaging techniques, and periprocedural and postprocedural antithrombotic regimens are creating new models for the diagnosis and successful endovascular treatment of intracranial stenosis. In this article, the most recent clinical developments and concepts for the diagnosis and endovascular treatment of intracranial atherosclerotic disease are discussed.
Medical subject headings
- Angioplasty
- Anticoagulants
- Atherosclerosis
- Carotid Artery Diseases
- Fibrinolytic Agents
- Neurosurgical Procedures
- Vascular Surgical Procedures